0001806952-20-000001.txt : 20200320 0001806952-20-000001.hdr.sgml : 20200320 20200320123509 ACCESSION NUMBER: 0001806952-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 EFFECTIVENESS DATE: 20200320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lyell Immunopharma, Inc. CENTRAL INDEX KEY: 0001806952 IRS NUMBER: 833006753 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363351 FILM NUMBER: 20731123 BUSINESS ADDRESS: STREET 1: 400 EAST JAMIE COURT STREET 2: SUITE 301 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650 695-0677 MAIL ADDRESS: STREET 1: 400 EAST JAMIE COURT STREET 2: SUITE 301 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001806952 Lyell Immunopharma, Inc. 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650 695-0677 DELAWARE None None Corporation true 2018 Richard Klausner c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Promoter Hans Bishop c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Director Catherine Friedman c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Director Robert Nelson c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Director Elizabeth Homans c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Stan Riddell c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Nicholas Restifo c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Margo Roberts c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Richard Goold c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Heather Turner c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Stephen Hill c/o Lyell Immunopharma, Inc. 400 E. Jamie Court, Suite 301 South San Francisco CA CALIFORNIA 94080 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-03-05 false true true Sale and issuance of Series C Preferred Stock ("Series C") and the underlying shares of Common Stock issuable upon conversion of Series C. false 0 492999957 492999957 0 false 10 0 0 0 false Lyell Immunopharma, Inc. /s/ Heather Turner Heather Turner Secretary 2020-03-12